Authors: RUNGE TM MCGINITY JW FRISBEE SE BRICENO JC OTTMERS SE CALHOON JH HANTLER CB KORVICK DL YBARRA JR

Citation: Tm. Runge et al., ENHANCEMENT OF BRAIN PO(2) DURING CARDIOPULMONARY BYPASS USING A HYPEROSMOLAR OXYGEN-CARRYING SOLUTION, Artificial cells, blood substitutes, and immobilization biotechnology, 25(3), 1997, pp. 297-308

Authors: BRICENO JC RUNGE TM MCGINITY JW FRISBEE SE OTTMERS SE KORVICK DL CALHOON JH MILLER OL HANTLER B CRUZEN OG YBARRA JR HOWELTON RV MIRELES RZ BENSON CK

Citation: Jc. Briceno et al., CHANGES IN BRAIN PH, PO2, PCO2, CEREBRAL BLOOD-FLOW, AND BLOOD CASES INDUCED BY A HYPEROSMOLAR OXYREPLETE HEMOSUBSTITUTE DURING CARDIOPULMONARY BYPASS, ASAIO journal, 43(1), 1997, pp. 13-18

Authors: CHARMAN WN CHARMAN SA MONKHOUSE DC FRISBEE SE LOCKHART EA WEISMAN S FITZGERALD GA

Citation: Wn. Charman et al., BIOPHARMACEUTICAL CHARACTERIZATION OF A LOW-DOSE (75 MG) CONTROLLED-RELEASE ASPIRIN FORMULATION, British journal of clinical pharmacology, 36(5), 1993, pp. 470-473